Northwest Biotherapeutics (NWBO) Reports Q3 Loss of $0.35/Share

Northwest Biotherapeutics (NASDAQ: NWBO) reported Q3 EPS of ($0.35), versus ($0.65) reported last year. Revenue for the quarter came in at $582 thousand, versus $400 thousand reported last year.

For earnings history and earnings-related data on Northwest Biotherapeutics (NWBO) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Investing.com’s stocks of the week
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak